Ahs Cancer Control Alberta

This study is for people aged 65 and older with a newly diagnosed aggressive brain cancer called glioblastoma who are too frail for standard long treatments. It compares chemotherapy alone to chemotherapy plus radiation to see if the chemo-only approach works just as well with fe…

This study looks at whether closely monitoring patients with mild to moderate liver inflammation from cancer immunotherapy and only giving steroids if needed works as well as giving high-dose steroids right away. About 56 adults with grade 2 or 3 immune-related hepatitis will be …

This study is for people with early-stage anal cancer that has not spread to the groin lymph nodes. It tests whether avoiding radiation to the groin is as effective as standard treatment while causing fewer side effects and improving quality of life. About 45 participants will re…

This study tests whether a daily inhaled steroid (budesonide), commonly used for asthma, can prevent lung inflammation from coming back in cancer patients who had a severe immune reaction to immunotherapy. About 94 adults with solid tumors who recently recovered from checkpoint i…

This study tests whether loratadine, a common allergy medicine, can prevent or reduce bone pain caused by a drug called G-CSF used during stem cell collection. About 78 adults with lymphoma or multiple myeloma will receive either loratadine or a placebo. The goal is to see if thi…

This study is for people with advanced esophageal cancer that cannot be cured. It tests whether adding two chemotherapy drugs (carboplatin and paclitaxel) to standard radiation therapy can better relieve trouble swallowing and improve quality of life. About 50 participants will r…

This study looks at whether people with multiple myeloma can safely give themselves a standard chemotherapy injection (bortezomib) at home, either by themselves or with a caregiver's help. About 100 adults who have already had at least four injections in a hospital will be taught…